Kirromycin


CAS No. : 50935-71-2

(Synonyms: Mocimycin; Delvomycin)

50935-71-2
Price and Availability of CAS No. : 50935-71-2
Size Price Stock
500μg $877 Get quote
1mg $1700 Get quote
5 mg Get quote
10 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-122386
M.Wt: 796.94
Formula: C43H60N2O12
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 50935-71-2 :

Kirromycin (Mocimycin; Delvomycin) is an elongation factor Tu (EF-Tu) inhibitor targeting protein biosynthesis. As an antibiotic, Kirromycin exerts antibacterial activity against Gram-negative bacteria by acting on EF-Tu to interfere with the peptidyl transfer reaction. Kirromycin is applicable to studies on bacterial infections[1][2][3]. In Vitro:Kirromycin (5 min) potently inhibits poly (U)-directed polyphenylalanine synthesis in an *E. coli* cell-free translation system, with an IC50 of 5 × 10-7 M[1].
Kirromycin (5 min) doubles the EF-T-dependent GTP hydrolysis activity, strongly inhibits EF-T-dependent peptide bond formation, and does not alter EF-T-mediated binding of Phe-tRNAPhe to ribosomes in the *Escherichia coli* ribosome assay system[1].
When incubated with EF-T and GTP for 5 min, kirromycin increases the binding amount of [3H]GTP to *Escherichia coli* EF-T to more than three times the original level[1].
Kirromycin (500 pmol; 10 min) induces Escherichia coli EF-T-dependent GTP hydrolysis in the absence of ribosomes or aminoacyl-tRNA; this activity is specifically activated only in the presence of Phe-tRNAPhe (but not uncharged tRNAPhe or Ac-Phe-tRNAPhe); it significantly enhances this activity in the presence of ribosomes; its GTP Km is 2 × 10-7 M, which is consistent with the GTP Km of ribosome- and Phe-tRNAPhe-dependent EF-T GTPase in the absence of antibiotics[1].
Kirromycin (1 nmol; 5 min) enables EF-T-dependent binding of Phe-tRNAPhe to poly (U)-ribosome complexes in *E. coli* in the absence of GTP, with the amount of [14C]Phe-tRNAPhe bound to ribosomes reaching 3.5 pmol[1].
At 4°C, kirromycin reduces the affinity of *E. coli* EF-Tu-GTP for aa-tRNA by approximately 3 orders of magnitude, resulting in a Kd of 2 μM; it also equalizes the affinity of *E. coli* EF-Tu-GDP for aa-tRNA to a Kd of 7 μM at 4°C, thereby eliminating the significant difference in affinity between EF-Tu-GTP and EF-Tu-GDP for aa-tRNA observed in the absence of this antibiotic[3].
Kirromycin (0.4-26 μM) binds to EF-Tu-GDP (as well as EF-Tu-GTP) from *E. coli* at a 1:1 molar ratio to form a complex, induces conformational changes that increase the net negative charge and electrophoretic mobility of EF-Tu, and exhibits an extremely low dissociation rate[3].

Your information is safe with us.